ArticleBMC pharmacology & toxicology2025
Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system.
Cheng Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it